Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Leukemia 8Breast Neoplasms 6Leukemia, Myeloid, Acute 5Pancreatic Neoplasms 4Congenital Abnormalities 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Head and Neck Neoplasms 3Testicular Germ Cell Tumor 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Colorectal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma, Testicular 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neuroblastoma 1

Interventions

Radiotherapy, Intensity-Modulated 2Radiotherapy 2Chemotherapy, Adjuvant 2X-Ray Therapy 1Therapeutics 1Physical Therapy Modalities 1Phlebotomy 1Neoadjuvant Therapy 1Immunologic Techniques 1Diffusion Tensor Imaging 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Esthesioneuroblastoma, Olfactory × Immunologic Techniques × Clear all
NCT00896896 2013-04-02

Immunoreactivity to Cetuximab in Cancer Patients

Vanderbilt-Ingram Cancer Center

Completed
538 enrolled
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Head and Neck Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Colorectal Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡